Reverse takeover

W Technologies, Inc. Signs Letter of Intent to Acquire 100% Curisin Corp through a Merger with a Subsidiary of W Technologies, Inc.

Retrieved on: 
Thursday, April 15, 2021

b'BEVERLY HILLS, Calif., April 15, 2021 /PRNewswire/ --W Technologies, Inc., ("W Tech or the Company"), (OTC: WTCG)announced today that it signed a non-binding letter of intent to acquire Curisin Corp. through a reverse merger with a wholly-owned subsidiary of the Company.

Key Points: 
  • b'BEVERLY HILLS, Calif., April 15, 2021 /PRNewswire/ --W Technologies, Inc., ("W Tech or the Company"), (OTC: WTCG)announced today that it signed a non-binding letter of intent to acquire Curisin Corp. through a reverse merger with a wholly-owned subsidiary of the Company.
  • Curisin recently acquired the assets of an accredited digital healthcare platform in India that will form the foundation for building possibly one of the largest blockchain healthcare platforms in the world.
  • Any such forward-looking information is expressly qualified in its entirety by this cautionary statement.
  • Moreover, the Company does not assume responsibility for the accuracy or completeness of such forward look information.

SHAREHOLDER ALERT: WeissLaw LLP Reminds FLIR, NTWN, OBLN, and GLUU Shareholders About Its Ongoing Investigations

Retrieved on: 
Friday, April 9, 2021

Under the terms of the merger agreement, NTWN will acquire Appgate through a reverse merger that will result in Appgate becoming a publicly traded company.

Key Points: 
  • Under the terms of the merger agreement, NTWN will acquire Appgate through a reverse merger that will result in Appgate becoming a publicly traded company.
  • Under the terms of the merger agreement, ReShape will acquire OBLN in an all-stock transaction, pursuant to which OBLN will be renamed ReShape Lifesciences Inc.
  • Under the terms of the agreement, the Company's shareholders will receive $12.50 in cash for each share of GLUU common stock that they hold.
  • If you own GLUUshares and wish to discuss this investigation or your rights, please call or visit our website: http://weisslawllp.com/gluu/
    View original content to download multimedia: http://www.prnewswire.com/news-releases/shareholder-alert-weisslaw-llp-r...

Yumanity Therapeutics Reports Full Year 2020 Financial Results and Recent Corporate Developments

Retrieved on: 
Wednesday, March 31, 2021

Yumanity made important scientific and operational progress throughout the course of the last year, said Richard Peters, M.D., Ph.D., President, Chief Executive Officer and Director of Yumanity.

Key Points: 
  • Yumanity made important scientific and operational progress throughout the course of the last year, said Richard Peters, M.D., Ph.D., President, Chief Executive Officer and Director of Yumanity.
  • Completed reverse merger with Proteostasis Therapeutics, Inc. on December 22, 2020 and commenced trading on the Nasdaq Capital Market on December 23, 2020, under the ticker symbol YMTX.
  • Closed $33.6 million common stock private investment in public equity (PIPE) transaction concurrently with the closing of the reverse merger.
  • General and administrative expenses: General and administrative expenses were $11.9 million and $7.1 million for the years ended December 31, 2020 and 2019.

Innovative Strategies Help Combat the Rise of Cybercrimes

Retrieved on: 
Tuesday, March 30, 2021

A number of major hacks have compromised local governmental agencies, healthcare organizations technology companies and many others in recent months.

Key Points: 
  • A number of major hacks have compromised local governmental agencies, healthcare organizations technology companies and many others in recent months.
  • Overall, it is the large enterprise segment that held the highest cyber security market share in 2019.
  • Aurora marks the first acquisition by Plurilock since completing its reverse takeover transaction in September 2020 when it began trading on the TSX Venture Exchange ("TSXV").
  • The Company will also bring more products and services to its clients without having to add additional vendors.

Innovative Strategies Help Combat the Rise of Cybercrimes

Retrieved on: 
Tuesday, March 30, 2021

A number of major hacks have compromised local governmental agencies, healthcare organizations technology companies and many others in recent months.

Key Points: 
  • A number of major hacks have compromised local governmental agencies, healthcare organizations technology companies and many others in recent months.
  • Overall, it is the large enterprise segment that held the highest cyber security market share in 2019.
  • Aurora marks the first acquisition by Plurilock since completing its reverse takeover transaction in September 2020 when it began trading on the TSX Venture Exchange ("TSXV").
  • The Company will also bring more products and services to its clients without having to add additional vendors.

Plurilock to Acquire Aurora Systems Consulting Inc.

Retrieved on: 
Monday, March 29, 2021

Aurora is a leading U.S.-based cybersecurity solutions provider with over 140 clients and revenue of US$28.11 million (CAD$35.82 million) in 2020

Key Points: 
  • Aurora marks the first acquisition by Plurilock since completing its reverse takeover transaction in September 2020 when it began trading on the TSX Venture Exchange ("TSXV").
  • Aurora will gain access to the Company's cutting-edge AI platform, resulting in a high-level of cross pollination between Plurilock's and Aurora's technology offerings.
  • "We are pleased to join Plurilock in delivering cybersecurity offerings to North American organizations across key industry verticals," said Philip de Souza, Founder and President of Aurora.
  • The Company entered into the Definitive Agreement with Plurilock Security Corp., the Company's wholly-owned U.S. subsidiary, Aurora and the shareholder of Aurora (the "Seller"), whereby Plurilock Security Corp. will acquire all of the outstanding securities of Aurora.

Champignon Brands Announces Filing of Listing Statement

Retrieved on: 
Friday, March 26, 2021

TORONTO, March 26, 2021 /PRNewswire/ - Champignon Brands Inc. (the "Company"), (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF), announced today that it has filed a new Listing Statement with the Canadian Securities Exchange ("CSE") which contains disclosure regarding the acquisition of AltMed Capital Corp. ("AltMed") (the "Transaction").

Key Points: 
  • TORONTO, March 26, 2021 /PRNewswire/ - Champignon Brands Inc. (the "Company"), (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF), announced today that it has filed a new Listing Statement with the Canadian Securities Exchange ("CSE") which contains disclosure regarding the acquisition of AltMed Capital Corp. ("AltMed") (the "Transaction").
  • The Transaction constituted a reverse takeover of Champignon by AltMed.
  • Champignon Brands Inc. ( https://champignonbrands.com )is a medical solutions company that aims to reduce the illness burden of brain-based mental disorders (e.g., major depressive disorder).
  • The Company has no obligation to update any forward-looking statement, even if new information becomes available.

Hemptown Provides Update on Proposed Qualifying Transaction

Retrieved on: 
Tuesday, March 23, 2021

The Transaction, once complete, is expected to result in the reverse takeover of Spectre (thereafter, referred to as the "Resulting Issuer") and will constitute Spectre's Qualifying Transaction under Policy 2.4 - Capital Pool Companies of the Exchange (the "CPC Policy").

Key Points: 
  • The Transaction, once complete, is expected to result in the reverse takeover of Spectre (thereafter, referred to as the "Resulting Issuer") and will constitute Spectre's Qualifying Transaction under Policy 2.4 - Capital Pool Companies of the Exchange (the "CPC Policy").
  • The Company is also pleased to announce changes to the proposed leadership team of the Resulting Issuer.
  • It is likely that trading in Spectre's common shares will not resume prior to the closing of the Transaction.
  • There can be no assurance that the transaction will be completed as proposed or at all.

SHAREHOLDER ALERT: WeissLaw LLP Reminds MDCA, FFG, PTVCA, and NTWN Shareholders About Its Ongoing Investigations

Retrieved on: 
Friday, March 19, 2021

Under the terms of the agreement, MDCA's shareholders will receive just 26% of the common equity of the post-transaction entity.

Key Points: 
  • Under the terms of the agreement, MDCA's shareholders will receive just 26% of the common equity of the post-transaction entity.
  • Under the terms of the agreement, the company's shareholders will receive $56.00 in cash for each share of FFG common stock that they hold.
  • Under the terms of the merger agreement, PTVCA shareholders will receive $23.30 in cash for each share of PTVCA common stock that they hold.
  • Under the terms of the merger agreement, NTWN will acquire Appgate through a reverse merger that will result in Appgate becoming a publicly traded company.

SHAREHOLDER ALERT: WeissLaw LLP Reminds VKIN, CLGX, VGAC, and RNET Shareholders About Its Ongoing Investigations

Retrieved on: 
Thursday, March 18, 2021

CEI currently owns approximately 62% of VKIN's issued and outstanding common shares.

Key Points: 
  • CEI currently owns approximately 62% of VKIN's issued and outstanding common shares.
  • Under the terms of the agreement, CLGX shareholders will receive $80.00 in cash for each share of CLGX common stock that they own.
  • Under the terms of the merger agreement, VGAC will acquire 23andMe through a reverse merger that will result in 23andMe becoming a public company traded on the NYSE.
  • Under the terms of the agreement, RNET shareholders will receive 0.1845 shares of Viasat stock per RNET share they hold, representing implied per-share merger consideration of approximately $9.92 based upon Viasat's March 17, 2021 closing stock price of $53.76.